• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Large-scale convalescent blood and plasma transfusion therapy for Ebola virus disease.

作者信息

Colebunders Robert L, Cannon Robert O

机构信息

Department of Clinical Sciences, Institute of Tropical Medicine Epidemiology and Social Medicine, University of Antwerp, Belgium.

Epidemiology and Social Medicine, University of Antwerp, Belgium.

出版信息

J Infect Dis. 2015 Apr 15;211(8):1208-10. doi: 10.1093/infdis/jiv043. Epub 2015 Jan 29.

DOI:10.1093/infdis/jiv043
PMID:25635120
Abstract
摘要

相似文献

1
Large-scale convalescent blood and plasma transfusion therapy for Ebola virus disease.埃博拉病毒病的大规模康复期血液及血浆输血治疗
J Infect Dis. 2015 Apr 15;211(8):1208-10. doi: 10.1093/infdis/jiv043. Epub 2015 Jan 29.
2
Evaluating large-scale blood transfusion therapy for the current Ebola epidemic in Liberia.评估针对利比里亚当前埃博拉疫情的大规模输血治疗。
J Infect Dis. 2015 Apr 15;211(8):1262-7. doi: 10.1093/infdis/jiv042. Epub 2015 Jan 29.
3
The ongoing evolution of antibody-based treatments for Ebola virus infection.埃博拉病毒感染的抗体疗法的持续演变。
Immunotherapy. 2017 Mar;9(5):435-450. doi: 10.2217/imt-2017-0010.
4
Treatment of Ebola virus infection with antibodies from reconvalescent donors.使用康复者捐献者的抗体治疗埃博拉病毒感染。
Emerg Infect Dis. 2015 Mar;21(3):521-3. doi: 10.3201/eid2103.141838.
5
Use of convalescent plasma in Ebola virus infection.康复期血浆在埃博拉病毒感染中的应用。
Transfus Apher Sci. 2017 Feb;56(1):31-34. doi: 10.1016/j.transci.2016.12.014. Epub 2016 Dec 30.
6
Specific neutralizing response in plasma from convalescent patients of Ebola Virus Disease against the West Africa Makona variant of Ebola virus.埃博拉病毒病恢复期患者血浆中针对西非马科纳变异株埃博拉病毒的特异性中和反应。
Virus Res. 2016 Feb 2;213:224-229. doi: 10.1016/j.virusres.2015.12.019. Epub 2015 Dec 29.
7
The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field.在资源有限环境中使用埃博拉康复期血浆治疗埃博拉病毒病：来自实地的观点
Clin Infect Dis. 2016 Jan 1;62(1):69-74. doi: 10.1093/cid/civ680. Epub 2015 Aug 10.
8
Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee.采用康复患者输血治疗埃博拉出血热。国际科学技术委员会。
J Infect Dis. 1999 Feb;179 Suppl 1:S18-23. doi: 10.1086/514298.
9
Do therapeutic antibodies hold the key to an effective treatment for Ebola hemorrhagic fever?治疗性抗体是埃博拉出血热有效治疗方法的关键所在吗？
Immunotherapy. 2013 May;5(5):441-3. doi: 10.2217/imt.13.29.
10
Ebola virus pathogenesis: implications for vaccines and therapies.埃博拉病毒发病机制：对疫苗和治疗的启示
J Virol. 2003 Sep;77(18):9733-7. doi: 10.1128/jvi.77.18.9733-9737.2003.

引用本文的文献

1
Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials.新型冠状病毒肺炎被动免疫治疗的最新进展：基于证据的方法和临床试验。
Int Immunopharmacol. 2022 Aug;109:108786. doi: 10.1016/j.intimp.2022.108786. Epub 2022 Apr 21.
2
An overview of some potential immunotherapeutic options against COVID-19.针对 COVID-19 的一些潜在免疫治疗选择概述。
Int Immunopharmacol. 2021 Jun;95:107516. doi: 10.1016/j.intimp.2021.107516. Epub 2021 Feb 26.
3
Correlation between SARS-COV-2 antibody screening by immunoassay and neutralizing antibody testing.
免疫测定法筛查 SARS-CoV-2 抗体与中和抗体检测的相关性。
Transfusion. 2021 Apr;61(4):1181-1190. doi: 10.1111/trf.16268. Epub 2021 Jan 25.
4
Effect and clinical value of coagulation test on adverse reactions of blood transfusion in patients with major bleeding in ectopic pregnancy.凝血检测对异位妊娠大出血患者输血不良反应的影响及临床价值
Exp Ther Med. 2018 Dec;16(6):4712-4716. doi: 10.3892/etm.2018.6804. Epub 2018 Sep 27.
5
The Role of the Laboratory and Transfusion Service in the Management of Ebola Virus Disease.实验室与输血服务在埃博拉病毒病管理中的作用
Transfus Med Rev. 2017 Jul;31(3):149-153. doi: 10.1016/j.tmrv.2016.11.002. Epub 2016 Nov 16.
6
Organizing the Donation of Convalescent Plasma for a Therapeutic Clinical Trial on Ebola Virus Disease: The Experience in Guinea.为埃博拉病毒病治疗性临床试验组织恢复期血浆捐赠：几内亚的经验
Am J Trop Med Hyg. 2016 Sep 7;95(3):647-653. doi: 10.4269/ajtmh.15-0890. Epub 2016 Jul 18.
7
Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow.针对传染性病原体的血浆疗法，关乎昨天、今天与明天。
Transfus Clin Biol. 2016 Feb;23(1):39-44. doi: 10.1016/j.tracli.2015.12.003. Epub 2016 Jan 6.
8
Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak.2014 - 2015年埃博拉疫情期间在几内亚进行的评估恢复期血浆治疗埃博拉病毒病的埃博拉治疗试验中的设计与分析考量
Clin Trials. 2016 Feb;13(1):13-21. doi: 10.1177/1740774515621056. Epub 2016 Jan 14.
9
A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response.用于高效评估埃博拉病毒治疗方法的反应适应性随机化平台试验：大流行应对模型。
Clin Trials. 2016 Feb;13(1):22-30. doi: 10.1177/1740774515621721. Epub 2016 Jan 14.
10
Convalescent plasma: new evidence for an old therapeutic tool?康复血浆：一种古老治疗手段的新证据？
Blood Transfus. 2016 Mar;14(2):152-7. doi: 10.2450/2015.0131-15. Epub 2015 Nov 6.